Form 4 for ONC BeOne Medicines Ltd.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001651308-23-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 | 2023-03-16 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -67.4K | 5.45M | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-16 | G | D | 67,444 | $0.00 | 5,445,112 | D | — | — | (F1) Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. |